Identification of Proinflammatory Flagellin Proteins in Supernatants of Vibrio cholerae O1 by Proteomics Analysis*S
暂无分享,去创建一个
K. Klose | A. Gewirtz | María A Rendón | J. Xicohtencatl-Cortes | J. Girón | M. Ledesma | Diana R. Hernandez | A. Chaparro | D. Hernandez | Sean Lyons | Zeus Saldaña | María A. Rendón
[1] S. Akira,et al. Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.
[2] N. Subramanian,et al. Lysophospholipid sensing triggers secretion of flagellin from pathogenic salmonella , 2006, Nature Immunology.
[3] J. Holmgren,et al. Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. , 2005, Current opinion in immunology.
[4] A. Talavera,et al. The Vaccine Candidate Vibrio cholerae 638 Is Protective against Cholera in Healthy Volunteers , 2005, Infection and Immunity.
[5] J. Kaper,et al. Induction of Interleukin-8 in T84 Cells by Vibrio cholerae , 2004, Infection and Immunity.
[6] S. Mizel,et al. Induction of Macrophage Nitric Oxide Production by Gram-Negative Flagellin Involves Signaling Via Heteromeric Toll-Like Receptor 5/Toll-Like Receptor 4 Complexes1 , 2003, The Journal of Immunology.
[7] P. Sansonetti,et al. The Contribution of Accessory Toxins of Vibrio cholerae O1 El Tor to the Proinflammatory Response in a Murine Pulmonary Cholera Model , 2002, The Journal of experimental medicine.
[8] A. Torres,et al. The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells , 2002, Molecular microbiology.
[9] C. Wennerås,et al. Increased Levels of Inflammatory Mediators in Children and Adults Infected with Vibrio cholerae O1 and O139 , 2002, Clinical and Vaccine Immunology.
[10] Shizuo Akira,et al. Toll-like receptors as adjuvant receptors. , 2002, Biochimica et biophysica acta.
[11] A. Delcour,et al. Vibrio cholerae OmpU and OmpT Porins Are Differentially Affected by Bile , 2002, Infection and Immunity.
[12] L. McCarter. Polar Flagellar Motility of theVibrionaceae , 2001, Microbiology and Molecular Biology Reviews.
[13] P. Godowski,et al. Cutting Edge: Bacterial Flagellin Activates Basolaterally Expressed TLR5 to Induce Epithelial Proinflammatory Gene Expression1 , 2001, The Journal of Immunology.
[14] J. Mekalanos,et al. Vibrio cholerae tolC Is Required for Bile Resistance and Colonization , 2001, Infection and Immunity.
[15] N. Caroff,et al. Nontoxigenic Vibrio Cholerae O1 Bacteremia: Case Report and Review , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[16] M. Waldor,et al. Regulation and Temporal Expression Patterns of Vibrio cholerae Virulence Genes during Infection , 1999, Cell.
[17] R. Clayton,et al. Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[18] Anisia J. Silva,et al. Preliminary Assessment of the Safety and Immunogenicity of a New CTXΦ-Negative, Hemagglutinin/Protease-Defective El Tor Strain as a Cholera Vaccine Candidate , 1999, Infection and Immunity.
[19] J. Madara,et al. Orchestration of Neutrophil Movement by Intestinal Epithelial Cells in Response to Salmonella typhimurium Can Be Uncoupled from Bacterial Internalization , 1999, Infection and Immunity.
[20] V. DiRita,et al. Analysis of ToxR‐dependent transcription activation of ompU, the gene encoding a major envelope protein in Vibrio cholerae , 1998, Molecular microbiology.
[21] T. Wassenaar,et al. Mode of primary binding to target membranes and pore formation induced by Vibrio cholerae cytolysin (hemolysin). , 1997, European journal of biochemistry.
[22] T. Postnova,et al. Motility mutants of Vibrio cholerae O1 have reduced adherence in vitro to human small intestinal epithelial cells as demonstrated by ELISA. , 1996, Microbiology.
[23] D. Milton,et al. Identification and characterization of additional flagellin genes from Vibrio anguillarum , 1996, Journal of bacteriology.
[24] Matthew K. Waldor,et al. Lysogenic Conversion by a Filamentous Phage Encoding Cholera Toxin , 1996, Science.
[25] J. Mekalanos,et al. Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression , 1996, Infection and immunity.
[26] C. Tacket,et al. New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae , 1996, Infection and immunity.
[27] V. Sperandio,et al. The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae , 1995, Infection and immunity.
[28] D. Spriggs,et al. Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. , 1995, The Journal of infectious diseases.
[29] M. Mathan,et al. Ultrastructural changes in the upper small intestinal mucosa in patients with cholera. , 1995, Gastroenterology.
[30] L. McCarter. Genetic and molecular characterization of the polar flagellum of Vibrio parahaemolyticus , 1995, Journal of bacteriology.
[31] J. Ezzell,et al. Development of a live, oral, attenuated vaccine against El Tor cholera. , 1994, The Journal of infectious diseases.
[32] J. Mekalanos,et al. Cholera vaccines: fighting an ancient scourge. , 1994, Science.
[33] M. Levine,et al. Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. , 1993, The Journal of infectious diseases.
[34] J. Kaper,et al. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] G. Mayrhofer,et al. Amino-terminal domain of the El Tor haemolysin of Vibrio cholerae O1 is expressed in classical strains and is cytotoxic. , 1991, Vaccine.
[36] K. Richardson. Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models , 1991, Infection and immunity.
[37] J. Kaper,et al. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Mekalanos,et al. Periplasmic interaction between two membrane regulatory proteins, ToxR and ToxS, results in signal transduction and transcriptional activation , 1991, Cell.
[39] D. Sack,et al. Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines. , 1990, Vaccine.
[40] C. Tacket,et al. SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR , 1988, The Lancet.
[41] M. Levine,et al. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques , 1988, Infection and immunity.
[42] V. L. Miller,et al. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[43] K. Richardson,et al. Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane , 1985, Infection and immunity.
[44] V. L. Miller,et al. Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[45] S. Attridge,et al. The role of the flagellum in the adherence of Vibrio cholerae. , 1983, The Journal of infectious diseases.
[46] R. Finkelstein,et al. Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. Freter,et al. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice , 1981, Infection and immunity.
[48] R. Peto. THE HORSE-RACING EFFECT , 1981, The Lancet.
[49] L. Cisneros,et al. Duration of infection-derived immunity to cholera. , 1981, The Journal of infectious diseases.
[50] A. D. Larson,et al. Characterization of a flagellar sheath protein of Vibrio cholerae , 1980, Infection and immunity.
[51] P. O’Farrell. High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.
[52] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[53] J. Girón. Role of Flagella in Mucosal Colonization , 2005 .
[54] J. Mekalanos,et al. Copyright © 1998, American Society for Microbiology Differential Regulation of Multiple Flagellins in Vibrio cholerae , 1997 .
[55] P. Blake,et al. Diseases of humans (other than cholera) caused by vibrios. , 1980, Annual review of microbiology.
[56] R. Yancey,et al. Motility of the pathogen and intestinal immunity of the host in experimental cholera. , 1978, Advances in experimental medicine and biology.
[57] B. Finlay,et al. Copyright © 1997, American Society for Microbiology Common Themes in Microbial Pathogenicity Revisited , 2022 .